CCIPD researchers receive awards

mri brain scans

Two researchers with the university’s Center for Computational Imaging and Personalized Diagnostics (CCIPD) recently received awards to advance their work.

Kaustav Bera, a CCIPD research associate, received the Early Career Travel Award from the International Association for the Study of Lung Cancer (IASLC).

Travel Awards are available for early career professionals and trainees to cover attendance at the annual IASLC 2019 World Conference on Lung Cancer. The conference will be held in Barcelona, Spain, in September.

Bera’s presentation at the World Conference on Lung Cancer is to develop a novel risk score that combines radiomics from CT scans, the quantitative mining of interpretable information from radiographic images, with relevant clinico-pathologic information, which includes the pathologic stage and lymphovascular invasion status, to predict how long patients of early-stage non-small cell lung cancer (the most common type of lung cancer) survive without any disease recurrence following surgery.

This research also incorporates significant radiomic information derived from outside the tumor in addition to intratumoral radiomics. The preliminary results showed that patients with a high risk score determined by the model had almost a four times worse risk of having the disease come back as compared to those with a low risk score.

The senior author on this abstract is Anant Madabhushi, the F. Alex Nason Professor II of Biomedical Engineering at Case Western Reserve University.

Yijiang Chen, a graduate research assistant with CCIPD, received the American Society of Nephrology (ASN) Pre-Doctoral Fellowship Award worth $10,000 annually for up to two years. In addition, Chen received a travel award to attend the ASN Annual Meeting and Kidney STARS program.

The goal of the ASN Pre-Doctoral Fellowship Award Program is to fund PhD students to conduct original, meritorious research projects. This program will foster early career-stage PhD students—under the direction of a sponsor—who are highly motivated to make contributions to the understanding of kidney biology and disease.

Madabhushi also advises Chen.

(From The Daily 7/5/2019)